Skip to main content

TBC Boehringer Ingelheim Pty Ltd

Product name
Accepted date
Active ingredients
empagliflozin, metformin hydrochloride
Proposed indication
As an adjunct to diet and exercise to improve glycaemic control in children aged 10 years and older with type 2 diabetes mellitus.
Application type
C (new medicine)
Publication date

Help us improve the Therapeutic Goods Administration site